Dana Antakly is an associate in the firm’s Business Law Department and a member of its Technology Companies and Life Sciences groups. Ms. Antakly represents public and private companies as well as venture capital funds and investment banks across the technology industry, including clients in the software, hardware, biotechnology, pharmaceuticals and other technology-driven industries. Her practice includes public and private securities offerings, mergers and acquisitions, and other complex transactions, as well as general corporate matters. She joined Goodwin in 2013.

Areas of Practice
Domaines D’Expertise





Ms. Antakly’s transactional experience includes representing:

  • Wayfair in its $500 million convertible notes offering 
  • J.P. Morgan and Credit Suisse in the $150 million follow-on offering of Everbridge
  • bluebird bio in several public offerings totaling more than $1 billion
  • HubSpot in its $144 million initial public offering, and $167 million and $310 million follow-on offerings”
  • Mimecast in its $77.5 million initial public offering and $62 million follow-on offering
  • AMAG Pharmaceuticals in its $300 million convertible notes offering
  • J.P. Morgan, Goldman Sachs and Morgan Stanley in the $287 million initial public offering of trivago
  • Morgan Stanley and Citigroup in the $240 million initial public offering of SailPoint Technologies and $400 million follow-on offering
  • Goldman Sachs and Deutsche Bank in the $100 million initial public offering of Acacia Communications and $450 million follow-on offering
  • J.P. Morgan in the $100 million initial public offering of InflaRx and $100 million follow-on offering
  • Barclays Capital in a $144 million offering of Carbonite
  • Novacap Industries in its acquisition of Dialogic
  • Ocata Therapeutics in its sale to Astellas Pharma
  • AppNexus in several strategic acquisitions 
  • Bit9 in its acquisition of Carbon Black
Professional Activities

Ms. Antakly is a member of the Boston Bar Association. While in law school, Ms. Antakly served as an Executive Editor for the Ottawa Law Review.

In The News









J.D., 2013
University of Ottawa

(magna cum laude)

B.S., 2010
McGill University
(with distinction)



Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique